OWC Pharmaceutical Research Corp. (OTCPK:OWCP) announced a private placement of 1,097,230 units at a price of $0.13 per unit for gross proceeds of $142,640 on January 9, 2017. Each unit consists of one restricted common share and one class G warrant and one class H warrant. Each class G warrant is exercisable at an exercise price of $0.25 for a period of 24 months, and each class H warrant is exercisable at an exercise price of $0.40 for a period of 36 months. The transaction included participation from accredited investors. The securities were issued pursuant to exemption provided under Regulation D and Regulation S.